Sumitomo Mitsui Trust Holdings, Inc. Horizon Therapeutics Public LTD CO Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$98.98 - $115.74 $872,706 - $1.02 Million	-8,817 Reduced 1.6%	543,189 $62.8 Million
Q2 2023 Jul 31, 2023	SELL	$96.34 - $112.38 $7.69 Million - $8.97 Million	-79,862 Reduced 12.64%	552,006 $56.8 Million
Q1 2023 Apr 27, 2023	SELL	$107.32 - $113.5 $2.11 Million - $2.23 Million	-19,621 Reduced 3.01%	631,868 $69 Million
Q4 2022 Jan 30, 2023	BUY	$62.39 - $113.8 $141,126 - $257,415	2,262 Added 0.35%	651,489 $74.1 Million
Q3 2022 Oct 21, 2022	BUY	$58.92 - $84.67 $167,214 - $240,293	2,838 Added 0.44%	649,227 $40.2 Million

Q2 2022 Jul 26, 2022	BUY	$79.4 - $116.36 $2.46 Million - $3.61 Million	31,038 Added 5.04%	646,389 $51.6 Million
Q1 2022 Apr 27, 2022	BUY	$86.42 - $109.81 $53.2 Million - $67.6 Million	615,351 New	615,351 $64.7 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.